✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Aarey Drugs & Pharmaceuticals Ltd.

AAREYDRUGS

Market Cap
₹203 Cr.
P/E
50.46

Aarey Drugs & Pharmaceuticals Ltd.

  • Aarey Drugs & Pharma
  • Syschem (India)
  • Bafna Pharma
FAQs on Aarey Drugs & Pharmaceuticals Ltd. Shareprice

Aarey Drugs & Pharma has given lower returns compared to its competitors.
Aarey Drugs & Pharma has grown at ~24.96% over the last 6yrs while peers have grown at a median rate of 34.28%

Yes, Aarey Drugs & Pharma is expensive.
Latest PE of Aarey Drugs & Pharma is 50.46, while 3 year average PE is 23.62.
Also latest EV/EBITDA of Aarey Drugs & Pharma is 105 while 3yr average is 29.55.

View FAQ's On Business
Growth Table
  • Aarey Drugs & Pharmaceuticals Ltd.
  • Syschem (India)
  • Bafna Pharma
Balance Sheet
  • Aarey Drugs & Pharmaceuticals Ltd.
  • Syschem (India)
  • Bafna Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Aarey Drugs & Pharmaceuticals Ltd.
  • Syschem (India)
  • Bafna Pharma
Cash Flow
  • Aarey Drugs & Pharmaceuticals Ltd.
  • Syschem (India)
  • Bafna Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Aarey Drugs & Pharmaceuticals Ltd.
  • Syschem (India)
  • Bafna Pharma
Quarterly Results
  • Aarey Drugs & Pharmaceuticals Ltd.
  • Syschem (India)
  • Bafna Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Aarey Drugs & Pharmaceuticals Ltd. Financials

Balance sheet of Aarey Drugs & Pharma is moderately strong.

Yes, The net debt of Aarey Drugs & Pharma is increasing.
Latest net debt of Aarey Drugs & Pharma is ₹33.38 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹29.66 Crs.

The profit is oscillating.
The profit of Aarey Drugs & Pharma is ₹4.02 Crs for TTM, ₹4.68 Crs for Mar 2024 and ₹3.77 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Aarey Drugs & Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech